Form 4: FormFactor Director Sheri Rhodes Receives RSU Grant

Director Sheri Rhodes was granted 1,347 restricted stock units as part of FormFactor's equity compensation program.

Summary

• Director Sheri Rhodes acquired 1,347 restricted stock units (RSUs) on May 15, 2026.
• The grant was approved by the Board in April 2026.
• Following this transaction, the reporting person holds a total of 11,703 shares of common stock.
• The RSUs vest monthly and become exercisable on the earlier of the 2027 Annual Meeting of Stockholders or May 15, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• RSUs are subject to forfeiture if the director ceases to provide services to the issuer, subject to specific policy exceptions.

Future Outlook

The RSUs are scheduled to vest monthly, becoming fully exercisable by May 15, 2027, or upon the 2027 Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the semiconductor equipment sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for mid-cap technology companies.
• The vesting schedule aligns with typical one-year director equity retention cycles.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of RSUs on the earlier of the 2027 Annual Meeting of Stockholders or May 15, 2027.

Key Dates

Keywords

FormFactor, FORM, Director, Insider Trading, Equity Compensation, RSU